Objective: To critically analyse literature on the anticancer properties of andrographolide in studies on gastric cancer cells.
Method: This study systematically reviewed articles from 2013 to 2024 across five prominent databases; PubMed, Google Scholar, Web of Science, Scopus, and Science Direct, EMBASE, Cochrane library and DOAJ. The study eligibility criteria include original studies assessing using gastric cancer cell lines and articles utilizing extracted andrographolide from or standard andrographolide source treatment.